Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Lover boy Lover boy
Aug 09, 2022 18:16
i need help
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
After-Hours Movers: Trade Desk Climbs After Results, Roblox and Coinbase Sink
© Reuters.
Investing.com Staff -
Magic Empire Global Ltd (NASDAQ:MEGL) +30%; shares declined 89% intraday.
The Trade Desk Inc (NASDAQ:TTD) +16%; reported Q2 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $377 million versus the consensus estimate of $364.87 million.GUIDANCE: The Trade Desk Inc. sees Q3 2022 revenue of at least $385 million, versus the consensus of $382.6 million.
Halozyme Therapeutics (NASDAQ:HALO) +8%; reported Q2 EPS of $0.53, $0.06 better than the analyst estimate of $0.47. Revenue for the quarter came in at $152.4 million versus the consensus estimate of $138.63 million. GUIDANCE: Halozyme Therapeutics sees FY2022 EPS of $2.10-$2.25, versus the consensus of $2.23. Halozyme Therapeutics sees FY2022 revenue of $655-685 million, versus the consensus of $610.9 million.
H&R Block (NYSE:HRB) +4.5%; reported Q2 EPS of $1.43, $0.19 better than the analyst estimate of $1.24. Revenue for the quarter came in at $1.05 billion versus the consensus estimate of $996.33 million. GUIDANCE: H&R Block sees FY2022 EPS of $3.70-$3.95, versus the consensus of $3.46. H&R Block sees FY2022 revenue of $3.535-3.585 billion, versus the consensus of $3.41 billion.
Roblox Corp (NYSE:RBLX) -13%; reported Q2 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $591.2 million versus the consensus estimate of $639.19 million. Average Daily Active Users (DAUs) were 52.2 million, up 21% year over year
Cano Health (NYSE:CANO) -8.8%; reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $689.4 million versus the consensus estimate of $712.61 million. GUIDANCE: Cano Health sees FY2022 revenue of $2.85-2.9 billion, versus the consensus of $2.86 billion.
Azenta Inc (NASDAQ:AZTA) -6.3%; reported Q3 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $133 million versus the consensus estimate of $138.73 million.
Coinbase (NASDAQ:COIN) -4%; reported Q2 EPS of ($4.98), may not compare the analyst estimate of ($2.44). Revenue for the quarter came in at $808.3 million versus the consensus estimate of $879.69 million.
Related Articles
Comments (1)
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.